T Cell Overview
Compound Volrustomig
Area under investigation
Advanced solid tumors, BTCs, Cervical cancer, Gastric/GEJ cancer, HCC, HNSCC, Mesothelioma, NSCLC, RCC
Scientific Pillar Immuno-Oncology
Compound Durvalumab
Advanced solid tumors, BRCAm or PALB2m breast cancer, BTCs, Endometrial cancer, Esophageal cancer, Gastric cancer, HCC, Metastatic urothelial carcinoma, Muscle-invasive bladder cancer, Non-muscle-invasive bladder cancer, NSCLC, RCC, SCLC, TNBC, Urothelial carcinoma, HER2-positive breast cancer
Compound Tremelimumab
Advanced solid tumors, HCC, Metastatic urothelial carcinoma, Muscle-invasive bladder cancer, NSCLC, SCLC
Compound Oleclumab
NSCLC
Compound Monalizumab
